Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Feb 29, 2024
Episode
207
Soundcloud
Share
Today’s episode of Lung Cancer Considered is part of our special series on seminal trials in thoracic oncology, focusing on the phase I study of the PD-1 inhibitor nivolumab. Hosts Dr. Narjust Florez and Dr. Stephen Liu discuss that study with guest Dr. Julie Brahmer from Johns Hopkins University. This podcast features surprise guest interviews with several doctors who were mentored by Dr. Brahmer.
Guest
Stephen Liu
MD
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Julie Brahmer
MD
Co-Director of the Upper Aerodigestive Department
Bloomberg-Kimmel Institute for Cancer Immunotherapy
Professor of Oncology at Johns Hopkins University
Elsa Anagnostou
MD
Co-Director
Lung Cancer Precision Medicine Center of Excellence
Patrick Forde
M.B.B.Ch.
Director of Thoracic Oncology - Clinical Research Program and Associate Professor
John Hopkins University
Jarushka Naidoo
MD
Medical Oncologist
Beaumont Hospital
